Literature DB >> 15510198

Novel mutations in the FLT3 gene in adult patients with refractory acute myeloid leukemia.

Y Choi, H-J Kim, B-H Park, W-S Min, C-C Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15510198     DOI： 10.1038/sj.leu.2403580

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation.

Authors:  Yung Chang Hsu; Mohane Selvaraj Coumar; Wen-Chieh Wang; Hui-Yi Shiao; Yi-Yu Ke; Wen-Hsing Lin; Ching-Chuan Kuo; Chun-Wei Chang; Fu-Ming Kuo; Pei-Yi Chen; Sing-Yi Wang; An-Siou Li; Chun-Hwa Chen; Po-Chu Kuo; Ching-Ping Chen; Ming-Hsine Wu; Chen-Lung Huang; Kuei-Jung Yen; Yun-I Chang; John T-A Hsu; Chiung-Tong Chen; Teng-Kuang Yeh; Jen-Shin Song; Chuan Shih; Hsing-Pang Hsieh
Journal:  Oncotarget       Date:  2016-12-27

2.  Quantitative fragment analysis of FLT3-ITD efficiently identifying poor prognostic group with high mutant allele burden or long ITD length.

Authors:  Y Kim; G D Lee; J Park; J-H Yoon; H-J Kim; W-S Min; M Kim
Journal:  Blood Cancer J       Date:  2015-08-14       Impact factor: 11.037
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.